Additionally, a preclinical study using an orthotopic 4T1.2 mouse model of spontaneously metastatic mammary cancer demonstrated that the effectiveness of neoadjuvant ICI treatment was dependent on functional Baft3+ and INF tumor changes, such as the initial step of CD-8+ T-cell recruitment into the microenvironment [30]. The gene discussed is CD8A; the disease is neoplasm.